Evaluation of dual nasal delivery of infectious hematopoietic necrosis virus and enteric red mouth vaccines in rainbow trout (Oncorhynchus mykiss)

Vaccine

Volumn 33, Issue 6, 2015, Pages 771-776

  LaPatra, Scott ^a   Kao, Samantha ^b   Erhardt, Erik B ^b   Salinas, Irene ^b  

^a CLEAR SPRINGS FOODS INC   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Dual vaccination; Enteric red mouth disease; Infectious hematopoietic necrosis virus; Nasal vaccines; Rainbow trout

Indexed keywords

BACTERIN; ENTERIC REDMOUTH VACCINE; INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; BACTERIAL VACCINE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUACULTURE; ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ENTERIC REDMOUTH DISEASE; HISTOPATHOLOGY; IMMERSION; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION PREVENTION; INFECTIOUS HEMATOPOIETIC NECROSIS; INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS; NONHUMAN; OLFACTORY NERVE; PISCICULTURE; PRIORITY JOURNAL; RAINBOW TROUT; SURVIVAL RATE; VACCINATION; YERSINIA RUCKERI; ANIMAL; FISH DISEASES; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MICROBIOLOGY; MORTALITY; ONCORHYNCHUS MYKISS; PROCEDURES; RHABDOVIRIDAE INFECTIONS; SURVIVAL; VETERINARY; VIROLOGY; YERSINIA INFECTIONS;

ADMINISTRATION, INTRANASAL; ANIMALS; BACTERIAL VACCINES; FISH DISEASES; IMMERSION; INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; ONCORHYNCHUS MYKISS; RHABDOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; VACCINATION; VIRAL VACCINES; YERSINIA INFECTIONS; YERSINIA RUCKERI;

EID: 84921613722     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.12.055     Document Type: Article

References (23)

1. Birkhoff M., Leitz M., Marx D. Advantages of intranasal vaccination and considerations on device selection. Indian J Pharm Sci 2009, 71(6):729-731.
2. Plant K.P., LaPatra S.E. Advances in fish vaccine delivery. Dev Comp Immunol 2011, 35(12):1256-1262.
3. Brudeseth B.E., Wiulsrod R., Frederiksen B.N., Lindmo K., Lokling K.E., Bordevik M., et al. Status and future perspectives of vaccines for industrialized fin-fish farming. Fish Shellfish Immunol 2013, 35:1759-1768.
4. Salinas I., Zhang Y-A., Sunyer J.O. Mucosal immunoglobulins and B cells of teleost fish. Dev Comp Immunol 2011, 35(12):1346-1365.
5. Busch R.A. Polyvalent vaccines in fish: the interactive effects of multiple antigens. Dev Biol Stand 1997, 90:245-256.
6. Lorenzen N., LaPatra S.E. DNA advances for aquacultured fish. Rev Sci Tech Off Int Epiz 2005, 24(1):201-213.
7. Tacchi L., Musharrafieh R., Crossey K., Larragoite E.T., Erhardt E.B., Martin S.A.M., et al. Nasal immunity is an ancient arm of the mucosal immune system of vertebrates. Nat Commun 2014, 5:5205.
8. LaPatra S., Clouthier S., Anderson E., Leung K. Current trends in immunotherapy and vaccine development for viral disease of fish 2004, World Sci Publishing Co. Pte. Ltd, Singapore.
9. Wiens G.D., Glenney G.W., LaPatra S.E., Welch T.J. Identification of novel rainbow trout (Onchorynchus mykiss) chemokines, CXCd1 and CXCd2: mRNA expression after Yersinia ruckeri vaccination and challenge. Immunogenetics 2006, 58:308-323.
10. Biering E., Villoing S., Sommerset I., Christie K.E. Update on viral vaccines for fish. Dev Biol (Basel) 2005, 121:91-113.
11. R Core Team R: a language and environment for statistical computing 2014, R Foundation for Statistical Computing, Vienna, Austria, http://www.R-project.org/.
12. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995, 57(1):289-300.
13. Neutra M.R., Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006, 6:148-158.
14. Lavelle E.C. Generation of improved mucosal vaccines by induction of innate immunity. Cell Mol Life Sci 2005, 62:2750-2770.
15. Matsuo K., Yoshikawa T., Asanuma H., Iwasaki T., Hagiwara Y., Chen Z., et al. Induction of innate immunity by nasal influenza vaccine administered in combination with an adjuvant (cholera toxin). Vaccine 2000, 18(24):2713-2722.
16. Piedra P.A., Gaglani M.J., Kozinetz C.A., Herschler G.B., Fewlass C., Harvey D., et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics 2007, 120(3):e553-e564.
17. Belshe R.B., Newman F.K., Anderson E.L., Wright P.F., Karron R.A., Tollefson S., et al. Evaluation of combined live, attenuated sysncytial virus and parainfluenza 3 virus vaccines in infants and young children. J Infect Dis 2004, 190:2096-2103.
18. Jun L., Jie L., Dongping Y., Xin Y., Taiming L., Rongyue C., et al. Effects of nasal immunization of multi-target preventive vaccines on artherosclerosis. Vaccine 2012, 30:1029-1037.
19. Sloat B.R., Shaker D.S., Le U.M., Cui Z. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induce strong antibody responses against all three antigens. FEMS Immunol Med Microbiol 2008, 52:169-179.
20. Sloat B.R., Cui Z. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli. Vaccine 2006, 24:6405-6413.
21. Aggerbeck H., Gizurarson S., Wantzin J., Heron I. Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine 1997, 15:307-316.
22. Beghaud L.J., Corbeil L.B., Berghaus R.D., Kalina W., Kimball K.A., Gershwin L.J. Effects of dual vaccination for bovine respiratory syncytial virus and Haemophilus somnus on immune responses. Vaccine 2006, 24:6018-6027.
23. Moore D.J., Orotake M., Nakanishi T. Particulate antigen uptake during immersion immunisation of fish: the effectiveness of prolonged exposure and the roles of skin and gill. Fish Shellfish Immunol 1998, 8(6):393-407.